Claudio Feliciani

26PUBLICATIONS
177CO-AUTHORS
AutoimmunityOral medicine and pathologyMolecular targetsAllergyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results.

Bianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni

|Sep 02, 2025
Mucocutaneous Leishmaniasis With Oral Involvement: A Case Report.

Pierpaolo De Francesco, Paolo Vescovi, Claudio Feliciani

|Jun 26, 2025
Genetics of Darier's Disease: New Insights into Pathogenic Mechanisms.

Barbara Moschella, Sabrina Busciglio, Enrico Ambrosini

|Sep 09, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study.

B M Piraccini, F Pampaloni, S Cedirian

|Jun 28, 2023
Severe Pemphigus Vulgaris Resistant to Conventional Therapies and with Hypersensitivity to Rituximab in a 12-Year-Old Child.

Maria Beatrice De Felici Del Giudice, Carolina Calanca, Chiara Sassetti

|Mar 25, 2023
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV).

Emiliano Antiga, Rikke Bech, Roberto Maglie

Pageof 5

Frequent Collaborators

9 joint publications

Angelo Valerio Marzano

6 joint publications

Pascal Joly

6 joint publications

Torello Lotti

6 joint publications

Luca Borradori